New T2D Medications and Technology Offer ' Bespoke ' Approach New T2D Medications and Technology Offer ' Bespoke ' Approach

Akshay Jain, MD, and Kevin Fernando, MSc, discuss highlights regarding incretin therapies and new technology for type 2 diabetes from the 83rd Annual ADA Scientific Sessions.Medscape Diabetes & Endocrinology
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news